Reuters logo
BRIEF-Infinity expects net loss for 2017 in the range of $40 mln to $50 mln
January 9, 2017 / 1:33 PM / a year ago

BRIEF-Infinity expects net loss for 2017 in the range of $40 mln to $50 mln

Jan 9 (Reuters) - Infinity Pharmaceuticals Inc :

* Infinity provides 2017 goals and financial guidance

* Infinity Pharmaceuticals Inc - expects to end 2017 with a year-end cash and investments balance ranging from $40 million to $50 million

* Infinity Pharmaceuticals Inc - expects net loss for 2017 to range from $40 million to $50 million.

* Infinity Pharmaceuticals - updated cash runway expectation assumes receiving $6.0 million milestone payment from verastem for positive duo study results

* Infinity Pharmaceuticals sees existing cash, cash equivalents, available-for-sale securities at Dec 31 2016 to be adequate to satisfy capital needs into Q1 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below